用生成式预训练变压器和深度强化学习优化化学空间中的结合亲和关系
Xiaopeng Xu1,2, Juexiao Zhou1,2, Chen Zhu3
1Computational Bioscience Research Center (CBRC), King Abdullah University of Science and Technology (KAUST), Thuwal, 23955-6900, Saudi Arabia.
F1000Research
|March 4, 2024
概括
一种新方法,SGPT-RL,使用生成预训练变压器 (GPT) 和强化学习 (RL) 来优化药物化合物结合亲和力. SGPT-RL在药物发现方面表现有前途,在特定任务中表现优于现有方法,并有助于设计新型主要候选药物.
科学领域:
- *计算化学和化学信息学.
- * 药物发现中的人工智能.
背景情况:
- * 在药物发现中,发现具有理想性质的新型化合物至关重要.
- *与目标的结合亲和力是关键的先决条件,通常使用分子对接或定量结构-活性关系 (QSAR) 模型进行评估.
研究的目的:
- * 开发和评估SGPT-RL,一种结合生成预训练变压器 (GPT) 和强化学习 (RL) 的新方法,以优化目标结合亲和力.
- *将SGPT-RL的表现与Reinvent方法在基准任务和目标定向生成方面进行比较.
主要方法:
- * SGPT-RL使用GPT作为RL代理的策略网络,以优化绑定亲和力.
- *评估涉及摩西分布学习基准和使用多巴胺受体D2 (DRD2) 和 ангиотензин转化酶2 (ACE2) 标的目标定向生成任务.
- * QSAR模型和分子对接都被用作优化目标.
主要成果:
- * SGPT-RL在摩西基准上显示出强大的财产分布,高有效性和新性.
- * SGPT-RL和Reinvent都产生了有效的分子,在目标定向任务中提高了目标得分.
- * SGPT-RL在ACE2任务中表现优于Reinvent,特别是当分子对接是优化目标时,并学习了保存的脚手架模式.
结论:
- * SGPT-RL在ACE2任务中的有效性表明其可用于利用分子对接的虚拟选过程.
- * 学习的脚手架模式可以帮助化学家设计新的候选者.
- * SGPT-RL代表了人工智能驱动的药物发现的进步,用于优化分子性质.
相关概念视频
Conserved Binding Sites
4.2K
Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally...
4.2K
Ligand Binding Sites
12.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
12.8K
The Equilibrium Binding Constant and Binding Strength
12.9K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
12.9K
Ligand Binding and Linkage
4.8K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.8K
The Two-State Receptor Model
1.9K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
1.9K
Drug-Receptor Bonds
2.8K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
2.8K


